Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Richard Andrew Newcomb, M.D.

Concepts (141)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematopoietic Stem Cell Transplantation17202557171.760 Why?
Hematologic Neoplasms9202419071.360 Why?
Lymphoma, Non-Hodgkin3202413750.760 Why?
Sexual Dysfunction, Physiological120243640.720 Why?
Quality of Life162024134900.660 Why?
Adaptation, Psychological6202426630.550 Why?
Immunotherapy, Adoptive3202415120.500 Why?
Lymphoma, B-Cell120219450.450 Why?
Graft vs Host Disease5202530490.400 Why?
Survivors4202423810.270 Why?
Leukemia, Myeloid, Acute4202336260.260 Why?
Neoplasms72024223710.240 Why?
Fatigue3202415570.220 Why?
Bronchiolitis Obliterans120252210.210 Why?
Anxiety6202446720.210 Why?
Neurotransmitter Agents219986630.210 Why?
Cyclophosphamide2202422270.190 Why?
Ischemic Attack, Transient219988770.190 Why?
Personal Satisfaction220246430.180 Why?
Burkitt Lymphoma120233380.180 Why?
Reperfusion Injury2199810390.170 Why?
Depression6202482300.170 Why?
Nitriles120259800.160 Why?
Hematologic Diseases120234980.160 Why?
Aged1920251715040.160 Why?
omega-Conotoxins11998170.150 Why?
Carcinoma, Large Cell120181140.150 Why?
Antigens, CD19120214460.150 Why?
fms-Like Tyrosine Kinase 3120214940.150 Why?
Humans4020257681660.140 Why?
Middle Aged1820252234920.140 Why?
Cross-Sectional Studies52024263790.140 Why?
Lymphoma, Follicular120214600.140 Why?
Bone Marrow Transplantation1202427090.130 Why?
Male2520253647190.130 Why?
Sarcopenia120213780.130 Why?
Hospitalization82024108400.130 Why?
Bone Marrow2202429350.120 Why?
Female2220253971920.120 Why?
Hospice Care120216780.120 Why?
Blood Coagulation1202011620.120 Why?
Pyrazoles1202520280.110 Why?
Palliative Care4202436430.110 Why?
Extracellular Space119965630.110 Why?
Potassium1199813150.110 Why?
Pilot Projects5202487410.110 Why?
Adult1520252236460.100 Why?
Pyrimidines1202530480.100 Why?
Leukemia, Lymphocytic, Chronic, B-Cell1202316420.100 Why?
Receptors, Antigen, T-Cell1202125680.100 Why?
Prognosis52024300100.100 Why?
Acute Kidney Injury1202319420.090 Why?
Venous Thrombosis1202013230.090 Why?
Inpatients2202425660.090 Why?
Terminal Care1202117700.080 Why?
Amino Acids1199617160.080 Why?
Microdialysis320011560.080 Why?
Retrospective Studies82024817620.080 Why?
Mass Screening1202454580.070 Why?
Anemia1201715140.070 Why?
Venous Thromboembolism1202018830.070 Why?
Pulmonary Embolism1202025990.070 Why?
Caregivers3202423020.070 Why?
Neoplasm Recurrence, Local2202394190.070 Why?
Prospective Studies42025549260.060 Why?
Patient Readmission1202032880.060 Why?
Muscle, Skeletal1202149780.060 Why?
Acute Disease2202472430.050 Why?
T-Lymphocytes12021102660.050 Why?
Glutamic Acid2200111910.050 Why?
Carcinoma, Squamous Cell1201840580.050 Why?
Immunotherapy1201847550.050 Why?
gamma-Aminobutyric Acid2200111410.050 Why?
Bilirubin120234380.050 Why?
Renal Replacement Therapy120232820.050 Why?
Bone Marrow Examination120211540.050 Why?
Cholecystitis120211810.040 Why?
Rabbits2199847720.040 Why?
Patient Satisfaction2202434880.040 Why?
Treatment Outcome52025653710.040 Why?
Neurotoxicity Syndromes120243020.040 Why?
Carcinoma, Non-Small-Cell Lung1201854320.040 Why?
Self Care120247990.040 Why?
Multicenter Studies as Topic1202417370.040 Why?
Patient Acceptance of Health Care2202332310.040 Why?
Longitudinal Studies22024147830.030 Why?
Patients120239080.030 Why?
Mutation12021302380.030 Why?
Transplantation, Homologous1202548330.030 Why?
Taurine11996920.030 Why?
Geriatric Assessment1202314220.030 Why?
Abdominal Pain1202110700.030 Why?
Tissue Donors1202423810.030 Why?
Body Temperature119987800.030 Why?
Age Factors22024184120.030 Why?
Calcium Channel Blockers119986870.030 Why?
Chromatography, High Pressure Liquid1199815340.030 Why?
Lung Neoplasms12018135860.030 Why?
Patient Education as Topic1202423370.030 Why?
Aspartic Acid119965770.030 Why?
Feasibility Studies1202453150.030 Why?
Basal Ganglia119965530.030 Why?
Cerebrospinal Fluid119965400.030 Why?
Social Support1202221930.020 Why?
Aged, 80 and over32024596290.020 Why?
Medication Adherence1202321870.020 Why?
Immunosuppressive Agents1202442060.020 Why?
Hemoglobins1201715310.020 Why?
Qualitative Research1202231400.020 Why?
Critical Illness1202327560.020 Why?
Cerebral Cortex2199858120.020 Why?
Intensive Care Units1202338000.020 Why?
Biopsy1202167930.020 Why?
Recurrence1202185090.020 Why?
Stress, Psychological1202445300.020 Why?
Brain Ischemia1200130070.020 Why?
Analysis of Variance1199662290.020 Why?
Patient Discharge1202034790.020 Why?
Nuclear Proteins1202158040.020 Why?
Randomized Controlled Trials as Topic12024103990.020 Why?
Clinical Trials as Topic1202280540.020 Why?
Young Adult22024600660.020 Why?
Severity of Illness Index12024159480.020 Why?
Regression Analysis1199663400.020 Why?
Peptides1199843540.020 Why?
Adolescent22024891690.020 Why?
Risk Factors22024749440.020 Why?
Incidence12023215380.020 Why?
Survival Rate12018128400.010 Why?
Antineoplastic Combined Chemotherapy Protocols12023118780.010 Why?
Laser-Doppler Flowmetry120012380.010 Why?
Risk Assessment12020243150.010 Why?
Blood Flow Velocity1200113750.010 Why?
Animals320011692460.010 Why?
Follow-Up Studies12018393480.010 Why?
Brain12001273600.010 Why?
Cerebrovascular Circulation1200127250.010 Why?
Mice, Inbred C57BL12001223790.000 Why?
Disease Models, Animal12001183490.000 Why?
Time Factors12001402180.000 Why?
Mice12001820290.000 Why?
Newcomb's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (141)
Explore
_
Co-Authors (66)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.